Market Tracker

03/23 8:08am ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

3.37
Delayed Data
As of Mar 22
 -0.19 / -5.34%
Today’s Change
3.05
Today|||52-Week Range
9.72
-36.29%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close3.56
Today’s open3.62
Day’s range3.35 - 3.75
Volume53,686
Average volume (3 months)158,781
Market cap$14.3M
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+49.44%
Earnings growth (this year)+32.59%
Earnings growth (next 5 years)--
Revenue growth (last year)+12.11%
P/E ratioNM
Price/Sales8.37
Price/Book0.53

Competitors

 Today’s
change
Today’s
% change
TNXPTonix Pharmaceutical...-0.22-5.93%
DPRXDipexium Pharmaceuti...0.000.00%
OGXIOncoGenex Pharmaceut...-0.02-3.77%
HEBHemispherx Biopharma...-0.03-4.87%
Data as of 03/22/2017

Financials

Next reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$1.9M
Annual profit (last year)-$14.3M
Net profit margin-737.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts